| Vol. 13.43 – 19 November, 2021 |
| |
|
|
| Golgi membrane protein 1 (GOLM1) was positively correlated with infiltrating tumor-associated macrophages expressed high levels of programmed death-ligand 1 (PD-L1) and CD8+ T cell suppression in hepatocellular carcinoma tissues. [Signal Transduction and Targeted Therapy] |
|
|
|
| PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators reported that interleukin-4 –induced M0 → M2 macrophage polarization was accompanied by interchangeable glucose- or lactate-dependent tricarboxylic acid cycle metabolism that directly drove histone acetylation, M2 gene transcription, and functional immune suppression. [Science Advances] |
|
|
|
| Using single-cell RNA and ATAC sequencing, researchers showed that virus-responding CD4+ T cells lacking both Bcl6 and Blimp1 could differentiate into cells with transcriptomic, chromatin accessibility, and functional attributes of memory cells but not of follicular helper T cells. [Journal of Experimental Medicine] |
|
|
|
| The presence of the p40-EBI3 heterodimer was confirmed by ELISA, immunoprecipitation, and western blotting. A p40-EBI3 vector and p40-EBI3-Fc protein were synthesized to confirm the immunological role of this protein in mice with collagen-induced arthritis [Cellular & Molecular Immunology] |
|
|
|
| Investigators showed that autotaxin (ATC) secreted by melanoma cells was chemorepulsive for tumor-infiltrating lymphocytes and circulating CD8+ T cells ex vivo, with autotaxin functioning as an LPA-producing chaperone. [Cell Reports] |
|
|
|
| Copper metabolism MURR1 domain (COMMD10) deficiency in Kupffer cells and in other tissue-resident macrophages impedes their homeostatic survival, leading to their continuous replacement by Ly6Chi monocytes. [Cell Reports] |
|
|
|
| The role of the CCL5 and IL4 in kidney fibrosis was studied by administration of the CCL5 receptor antagonist maraviroc or by injections of an anti-IL4 neutralizing antibody. [Hypertension] |
|
|
|
| Scientists found that oncolytic adenovirus conferred an effective ability to reduce ascites development and prolong overall survival. [Molecular Therapy-Oncolytics] |
|
|
|
| Researchers examined the efficacy of anti-TNFR2 antibody as an anti-tumor immune reagent combined with HMGN1and R848. [International Immunopharmacology] |
| |
|
|
|
| The authors highlight recent studies focusing on cellular interactions that regulate tissue resident memory T cells establishment and function. [Current Opinion in Immunology] |
|
|
|
| Investigators summarize the roles of different T cells and macrophages subsets in the occurrence and progression of rheumatoid arthritis (RA), and highlighted the immune consequences of cholinergic anti-inflammatory pathway activation in these cells under RA circumstances. [Neurochemical Research] |
|
|
|
|
| Revelation Biosciences, Inc. announced the initiation for its Phase Ib proof-of-concept nasal allergen challenge clinical study to evaluate the potential utility of REVTx-99 for treating patients with allergic rhinitis and patients with chronic nasal congestion without polyps. [Revelation Biosciences, Inc.] |
|
|
|
| Horizon Therapeutics plc announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion recommending marketing authorization for UPLIZNA® as a monotherapy for the treatment of adult patients with NMOSD. [Horizon Therapeutics plc] |
|
|
|
|
November 28 – December 1, 2021 Edinburgh, Scotland, United Kingdom |
| |
|
|
|
| UC San Diego Health – La Jolla, California, United States |
|
|
|
| AbCellera – Vancouver, British Columbia, Canada |
|
|
|
| University Medical Center Schleswig-Holstein – Kiel, Germany |
|
|
|
| Oregon Health & Science University – Portland, Oregon, United States |
|
|
|
| Ohio University – Columbus, Ohio, United States |
|
|
|
|